Seneviratne, 6 patient povidone-iodine late treatment RCT: 33% improved viral clearance [p=0.01] https://c19p.org/seneviratne
copied to clipboard
Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore
et al., Infection, doi:10.1007/s15010-020-01563-9
Small mouthwash RCT with 4 PVP-I patients and 2 water patients concluding that PVP-I may have a sustained effect on reducing the salivary SARS-CoV-2 level in COVID-19 patients. ISRCTN95933274.
|
relative fold change, 32.9% better, RR 0.67, p < 0.01, treatment 4, control 2, PVP-I vs. water, 6 hours.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Seneviratne et al., 12/14/2020, Randomized Controlled Trial, Singapore, Asia, peer-reviewed, 12 authors.
Late treatment
is less effective
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.